Publicación:
Comparison of high titer Edmonston-Zagreb, Biken-CAM and Schwarz measles vaccines in Peruvian infants

dc.contributor.authorBerry, Susan
dc.contributor.authorHernandez, Herminio
dc.contributor.authorKanashiro, Rosa
dc.contributor.authorCampos, Miquel
dc.contributor.authorAzabache, Veronica
dc.contributor.authorGomez, Grimanesa
dc.contributor.authorGutierrez, Manuel
dc.contributor.authorWeirs, Brook
dc.contributor.authorDe quadros, Ciro
dc.contributor.authorHalsey, Neal
dc.date.accessioned2026-05-14T14:28:49Z
dc.date.issued1992
dc.description.abstractIn an effort to identify the optimal dose and strain of measles vaccination for early immunization, Peruvian infants were randomly assigned to receive one of three measles vaccines in varying doses at 5 to 6 or 8 to 9 months of age. Edmonston-Zagreb vaccines were significantly (P < 0.001) more immunogenic than equivalent or higher titers of Schwarz or Biken-CAM vaccines as determined by neutralization antibody response 3 months after vaccination. Eighty-two percent of infants who received high titer Edmonston-Zagreb vaccine at 5 to 6 months of age developed protective concentrations of measles antibody, a response rate similar to that observed after standard titer Schwarz (81%) or high titer Biken-CAM vaccine (81%) at 8 to 9 months of age. No significant differences in the rates of fever, rash or other adverse events were noted by vaccine group 10 to 14 days after vaccination. Although the high titer vaccines are more immunogenic in young infants than standard vaccines, long term safety must be assured before these vaccines can be put into widespread use. © 1992 by Williams and Wilkins.en_US
dc.identifier.doihttps://doi.org/10.1097/00006454-199210000-00003
dc.identifier.scopus2-s2.0-0026686759
dc.identifier.urihttps://hdl.handle.net/20.500.12866/19724
dc.language.isoeng
dc.publisherLippincott Williams & Wilkins
dc.relation.ispartofurn:issn:0891-3668
dc.relation.ispartofseriesPediatric Infectious Disease Journal
dc.relation.issn0891-3668
dc.rightshttp://purl.org/coar/access_right/c_14cb
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectBiken-CAMen_US
dc.subjectEdmonston-Zagreben_US
dc.subjectImmune responseen_US
dc.subjectImmunizationen_US
dc.subjectMaternal antibodiesen_US
dc.subjectMeasles vaccineen_US
dc.subjectPeruen_US
dc.titleComparison of high titer Edmonston-Zagreb, Biken-CAM and Schwarz measles vaccines in Peruvian infantsen_US
dc.typehttps://purl.org/coar/resource_type/c_2df8fbb1
dc.type.localArtículo de revista
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dspace.entity.typePublication

Archivos